PE ratio relative to earnings growth — is the valuation justified?
| Symbol | Company | PEG | P/E | Growth | vs SYK |
|---|---|---|---|---|---|
| BSX | Boston Scientific Corporation | 0.30 | 19.1 | 63.3% | -89% |
| ZBH | Zimmer Biomet Holdings, Inc. | 0.65 | 23.9 | 36.8% | -75% |
| BDX | Becton, Dickinson and Company | 2.47 | 40.2 | 16.3% | -6% |
| ABT | Abbott Laboratories | 4.09 | 33.6 | 8.2% | +55% |
| EW | Edwards Lifesciences Corporation | 6.95 | 47.7 | 6.9% | +164% |